top of page

A Unique Patient Presentation of Disseminated Strongyloidiasis: Unraveling the Clinical Complexity of an Immunocompromised Patient

Updated: Jan 29

Lorena Bonilla


Please click here to see the paper:


About the Authors: Dr. Lorena Del Pilar Bonilla is a second-generation Ecuadorian American. Dr. Bonilla joined Baptist Health Medical Group as an internal Medicine physician. As Assistant Professor at FIU/Herbert Wertheim College of Medicine she actively teaches hospital medicine to resident physicians and medical students.


Dr. Bonilla is a co-founder of Doctors for Camp Closure in Florida and collaborates with multiple immigrant advocacy groups to increase awareness on the health of immigrants in detention. She serves as a Regional Advisor to the Southeast Regional Latino Medical Student Association (LMSA). In this role she has been a speaker who educates medical students and residents on health topics including wellness, burnout, and immigrant advocacy.


Dr. Bonilla is passionate about promoting wellbeing, addressing health disparities, mentoring students, and using her clinical expertise to advocate for vulnerable communities.


Lorena Del Pilar Bonilla MD, MS, FACP

Community-Based Clinical Assistant Professor of Translational Medicine, FIU Herbert Wertheim College of Medicine.

Baptist Health Medical Group Hospitalist

Board Certified in Internal Medicine


About the Work: Strongyloidiasis is a rare parasitic disease that can remain dormant and asymptomatic in many individuals. However, in cases of immunosuppression, the motility rate of the Strongyloides parasite increases significantly. This case study presents a unique clinical scenario involving an 88-year-old Hispanic male with a disseminated Strongyloides infection. The patient's medical history includes coronary artery disease, a history of percutaneous coronary intervention, heart failure with reduced ejection fraction and subsequent recovery of left ventricular function, hypertension, dyslipidemia, mantle cell lymphoma being treated with rituximab every two months since 2019, and chronic anemia. This case emphasizes the importance for physicians to consider strongyloidiasis when faced with a diverse range of symptoms, including syndrome of inappropriate antidiuretic hormone secretion (SIADH), rash, gastrointestinal upset, urinary retention, chronic anemia, and chronic eosinophilia, as these manifestations may share a common origin.

6 views0 comments

コメント


bottom of page